Last update:

HIV & AIDS news


Lenacapavir reduces viral load in multidrug-resistant HIV-1 infection

Patients with multidrug-resistant HIV-1 infection receiving the capsid inhibitor lenacapavir have a greater reduction in viral load than those receiving placebo, according to a study published in the May 12 issue of the New ...


Decline in the number of people diagnosed with HIV in New Zealand

The number of people being diagnosed with HIV in New Zealand continues to decline, figures released today by the University of Otago's AIDS Epidemiology Group show.


The antibodies of 'post-treatment HIV controllers'

A very small percentage of people with HIV-1, known as "post-treatment controllers" (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding the fundamental mechanisms that ...


Climate change reduces HIV treatment adherence in Africa

Droughts caused by climate change can have an impact on HIV treatment, according to a new study led by researchers at Brighton and Sussex Medical School (BSMS), Africa Health Research Institute (AHRI) and the University of ...


HIV pre-exposure prophylaxis works but needs regular testing

HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials demonstrated that PrEP effectively ...

Medical research

Uncovering the HIV life cycle

Though it has been eclipsed lately by SARS-CoV-2, there is another global epidemic still threatening people: HIV/AIDS. According to UNAIDS, a United Nations initiative, some 38 million people worldwide are currently infected ...


HIV hides within immune system's 'police stations'

Antiretroviral therapy (ART) is highly effective at controlling HIV infections, but the virus never completely goes away. Instead, it hides in roughly one in every 1 million immune cells.

Oncology & Cancer

Blood test figures in cancer risk for people with HIV

In the clinical care of people living with HIV, various types of blood cells are routinely counted to assess the immune system, among them CD4+ cells, or T helper cells, and CD8+ cells, or cytotoxic T cells.